Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash from Investing Activities (2016 - 2020)

Historic Cash from Investing Activities for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to -$1000.0.

  • Forte Biosciences' Cash from Investing Activities rose 9998.27% to -$1000.0 in Q3 2020 from the same period last year, while for Dec 2020 it was $3.6 million, marking a year-over-year increase of 231111.11%. This contributed to the annual value of -$36.0 million for FY2024, which is 7668085.11% down from last year.
  • Forte Biosciences' Cash from Investing Activities amounted to -$1000.0 in Q3 2020, which was up 9998.27% from -$9.1 million recorded in Q2 2020.
  • Forte Biosciences' Cash from Investing Activities' 5-year high stood at $12.7 million during Q1 2020, with a 5-year trough of -$28.4 million in Q4 2017.
  • Over the past 5 years, Forte Biosciences' median Cash from Investing Activities value was $756000.0 (recorded in 2018), while the average stood at -$205789.5.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 26653.92% in 2019, then crashed by 215098.52% in 2020.
  • Forte Biosciences' Cash from Investing Activities (Quarter) stood at $6.8 million in 2016, then tumbled by 515.28% to -$28.4 million in 2017, then surged by 102.66% to $756000.0 in 2018, then crashed by 111.77% to -$89000.0 in 2019, then surged by 98.88% to -$1000.0 in 2020.
  • Its Cash from Investing Activities was -$1000.0 in Q3 2020, compared to -$9.1 million in Q2 2020 and $12.7 million in Q1 2020.